Remove Dosage Remove Labelling Remove Presentation
article thumbnail

Labelling of Dispensed Medicine

RX Note

Labelling Requirements A ll dispensed medicine should be labelled according to the requirement stated by the law. NOTE: It is advisable for labels to be printed. Consequently, a patient-centred label strategy is introduced to promote appropriate medication use and adherence. 12 point and above).

article thumbnail

Rising demand for pediatric dosage forms requires reformulation, expertise, and to-scale manufacturing capabilities

Pharmaceutical Technology

Pharmaceutical companies are looking to paediatric indications of approved adult dosage forms (ADFs) to sustain and fuel growth. Various modifications to adult dosage forms (ADFs) are often needed to make a drug easier for children to take and easier for parents to administer. Innovative solutions to complex challenges.

Dosage 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Sandoz granted novel biosimilars approval

European Pharmaceutical Review

As US-approved biosimilars, Wyost and Jubbonti have the same dosage form, route of administration, dosing regime and presentation as the Xgeva ® and Prolia ® , which are are registered trademarks of Amgen Inc. The approval is also accompanied by labelling with safety warnings.

article thumbnail

Over-the-Counter Choices Pharmacist Role and Resources

FADIC

OTC drugs come in various forms, including tablets, capsules, creams, and liquids, and are generally labeled with clear instructions on proper usage and dosage. The FDA’s website provides a wealth of information on OTC drugs, including product labels, warnings, and recalls.

article thumbnail

The IMA Group at ACHEMA 2024 : All-In-One solutions for the pharmaceutical sector

European Pharmaceutical Review

The ADAPTA 50 capsule filler features innovative technical solutions to manage complex solid dosage forms such as product combination in hard gelatine capsules or powder micro-dosing for Dry Powder Inhalers. customers will have the opportunity to experience first hand various digital solutions aimed at reducing maintenance costs and downtime.

article thumbnail

Novartis gets positive CHMP opinion for Kisqali in early breast cancer

Pharmaceutical Business Review

The positive opinion from CHMP is based on the results from the Phase III NATALEE trial, which is a global, multi-centre, open-label study. The safety profile of Kisqali at the 400mg dosage was also highlighted as well-tolerated, with most adverse events being of low grade. This also includes those with node-negative disease.

Dosage 52
article thumbnail

Almirall/Lilly lebrikizumab offers potential long-term management of atopic dermatitis

pharmaphorum

Findings presented at EADVC 2022. The question now is how to tailor dosage even more closely to fit patients’ needs. “[L]ess Full results of the phase 3 study are due to be published in a peer-reviewed journal, and Almirall and Lilly are to submit regulatory applications to the EU and US, respectively, this year also.